As a recipient of one of 46 national Clinical and Translational Science Awards (CTSA), the Mayo Clinic has a strong translational research program. UMMC has significant basic-science expertise and unique epidemiological research programs especially in hypertension, cardiovascular disease and renal disease. But it is still working to develop its clinical research infrastructure.
"UMMC has the opportunity to develop leading clinical and population-research programs. We are strong in some areas of basic science research and need more translational and clinical investigations," Hall said. The CTSAs are administered by the National Institutes of Health's National Center for Research Resources.
Researchers at the Mayo Clinic will gain access to the Mississippi patient population, which has some of the nation's highest rates of heart disease, obesity, diabetes, stoke and hypertension.
As well, Mississippi has an African-American population particularly affected by those diseases that otherwise would not be easily accessible for Mayo researchers, Hall said.
The importance of biomedical research to understand and reverse health disparities, particularly in African-American populations, can't be overstated. UMMC and two historically black institutions, Jackson State University and Tougaloo College, are a decade into the Jackson Heart Study. The study investigates cardiovascular disease among 5,300 African-Americans in Mississippi's Capital. It's the nation's largest longitudinal study of cardiovascular disease risk factors in African-Americans.
UMMC is also a principal site for the 20-year-running Atherosclerosis Risk in Communities Study, a larger population study, in which about a quarter of the 16,000 participants are African-Americans f
|Contact: Jack Mazurak|
University of Mississippi Medical Center